Document is current
Any future updates will be listed below
-
Authors
Kinge, Jonas Minet https://orcid.org/0000-0002-2789-6113
Dieleman, Joseph L.
Karlstad, Øystein
Knudsen, Ann Kristin
Klitkou, Søren Toksvig
Hay, Simon I.
Vos, Theo
Murray, Christopher J. L.
Vollset, Stein Emil
-
Funding
Funding for this research was provided by:
Norges Forskningsråd (262700)
Norwegian Institute of Public Health
- License Information
-
More Information
Article History
Received: 27 February 2023
Accepted: 9 May 2023
First Online: 6 June 2023
Declarations
:
: The study was conducted on de-identified health care encounter data from national health registries. The study was approved, and participant consent was waived, by the Regional Committee for Medical and Health Research Ethics South-East Norway, reference number 184544.
: Not applicable.
: Søren Toksvig Klitkou, formerly employed by the Norwegian Institute of Public Health, is currently an employee of MSD Norway, a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, which manufactures drugs and vaccines.Øystein Karlstad reports participation in research projects funded by Novo Nordisk, LEO Pharma, and Bristol Myers Squibb, all regulator-mandated phase IV studies, all with funds paid to his institution (no personal fees), outside of the submitted work.The other authors declare that they have no competing interests.
